These essential public speaking truths will help you engage your audience, increase your confidence, and deliver ...

Astellas Pharma US, Inc. (Head of US Commercial: Michael Petroutsas, "Astellas") today announced new research insights at the American Society of Retina Specialists (ASRS) Annual Scientific Meeting, ...

Genmab A/S(Nasdaq: GMAB) today announced topline results from the Phase 3 EPCORE DLBCL-4 trial evaluating the combination of fixed duration epcoritamab, a T-cell engaging bispecific antibody ...

AbbVie today announced topline results from the Phase 3 EPCORE DLBCL-4 trial evaluating the combination of epcoritamab, a T-cell engaging bispecific antibody, and lenalidomide, compared to rituximab ...

Welcome to Aethlon Medical's Fiscal Year-End March 31, 2026, Earnings Conference Call. My name is Jim Frakes, and I'm the ...

Sony introduces the LYTIA 610 mobile image sensor featuring a 64MP resolution, RB2x2 On-Chip Lens structure, and 4K 120fps ...

Oklahoma health officials approved a 2027 budget after receiving only half of their requested funding increase.

Before the advent of JAK inhibitors, we did not have any effective therapy for patients with myelofibrosis. We could offer ...

Lone-star ticks don’t just pursue and bite people. The affliction they’re spreading, an allergy to red meat known as ...

Genmab A/S(Nasdaq: GMAB) today announced new data from a post-hoc subgroup analysis from the pivotal Phase 3 EPCORE ® FL-1 trial, evaluating epcoritamab,a subcutaneous T-cell engaging bispecific ...

On this "Face the Nation with Margaret Brennan" broadcast, Sens. Bill Cassidy and Tim Kaine join Margaret Brennan.

As you all know, Alnylam is pioneering an entirely new class of medicines to treat human disease. This generational technology leverages the mechanism of RNA interference, a natural process of gene ...